Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2020.
The company has reported 2- fold jumps in its net profit of Rs 318.64 crore for the quarter under review as against Rs 155.22 crore for the same quarter in the previous year. Total income of the company increased 39.86% at Rs 1258.59 crore for Q1FY21 as compared Rs 899.92 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported over 2- fold jumps in its net profit after taxes, non-controlling interests and share of profit of Associates and Joint Ventures at Rs 301.46 crore for the quarter under review as against Rs 123.72 crore for the same quarter in the previous year. Total income of the company increased by 40.90% at Rs 1341.64 crore for Q1FY21 as compared Rs 952.20 crore for the corresponding quarter previous year.
